stockrowAlkermes plc (ALKS) vs Dr. Reddy's Laboratories Ltd (RDY)
- Alkermes plc ALKS 44.61 −2.79%
- Dr. Reddy's Laboratories Ltd RDY 14.53 −1.62%
Alkermes plc and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Dr. Reddy's Laboratories Ltd is the larger, with a market value of $12.1B against $7.5B — 1.6× the size. Alkermes plc has negative trailing earnings, so its P/E is not meaningful; Dr. Reddy's Laboratories Ltd trades at 44.4×. Alkermes plc grew revenue faster over the last twelve months: 15.3% against −15.5%. Dr. Reddy's Laboratories Ltd has the higher net margin (8.06% vs −0.02%) and the higher return on invested capital (4.77% vs 1.54%). Across the 21 metrics below, Dr. Reddy's Laboratories Ltd leads on 13 and Alkermes plc on 8.
Valuation
Profitability
| Metric | ALKS | RDY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 82.89% | 49.16% | 53.51% |
| Operating margin | 3.66% | 9.20% | 0.00% |
| Net margin | (0.02%) | 8.06% | (2.45%) |
| Free cash flow margin | 13.03% | 2.88% | 0.00% |
| Return on equity | (0.02%) | 6.60% | (0.80%) |
| Return on assets | (0.01%) | 4.44% | (1.67%) |
| Return on invested capital | 1.54% | 4.77% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack